Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2026)
Atea Pharmaceuticals' Tax Provisions came in at $24,000 for Q2 2026, down 88.4% from $207,000 a year earlier and down 52.0% from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Tax Provisions (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Atea Pharmaceuticals reported Tax Provisions of -$6.5 million; for FY2025, it came in at -$6.16 million.
- Going back by year, Tax Provisions was $925,000 in FY2024 (-9.1%), $1.02 million in FY2023, -$3.59 million in FY2022 and $17.4 million in FY2021.
- The five-year range for quarterly Tax Provisions is -$6.77 million (Q4 2025) to $6.1 million (Q3 2021).
- Year-over-year, Tax Provisions increased in 1 of the last seven quarters, with an average decline of 33.9%.
- The fastest year-over-year change in Tax Provisions over five years came in Q4 2023 (growth of 183.7%), and the weakest in Q2 2022 (a decline of 98.3%).
- Business Quant data shows AVIR's Tax Provisions at $50,000 (Q1 2026), -$6.77 million (Q4 2025) and $196,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 1.96 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -176.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 609.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 492.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -842.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 822.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 634.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 134.00 Mn |
| 10 | Atea Pharmaceuticals | 337.28 Mn | -631.22 Mn | - | 38,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 38,000.00 |
| Jun 30, 2026 | 24,000.00 |
| Mar 31, 2026 | 50,000.00 |
| Dec 31, 2025 | -6.77 Mn |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 207,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 243,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | 349,000.00 |
| Sep 30, 2023 | 221,000.00 |
| Jun 30, 2023 | 251,000.00 |
| Mar 31, 2023 | 197,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | -3.83 Mn |
| Jun 30, 2022 | 120,000.00 |
| Dec 31, 2021 | 4.10 Mn |
| Sep 30, 2021 | 6.10 Mn |
API Access
Atea Pharmaceuticals Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();